InvestorsHub Logo
Followers 82
Posts 3648
Boards Moderated 0
Alias Born 02/15/2010

Re: frrol post# 55226

Tuesday, 03/01/2016 1:53:06 PM

Tuesday, March 01, 2016 1:53:06 PM

Post# of 456737
Prana's drug was a good candidate for failure. It was not reversing the effects of Alzheimer's like A2-73, just possibly slowing progression.

Macfarlane's enthusiasm during the Prana trial was directed at one patient. Currently, his enthusiasm is for the whole trial.

Macfarlane said that the drug seems to have slowed the progression of the disease by about 30 percent in patients with mild Alzheimer’s compared to placebo.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News